Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup

RA Sperling, CR Jack Jr, SE Black, MP Frosch… - Alzheimer's & …, 2011 - Elsevier
Amyloid imaging related abnormalities (ARIA) have now been reported in clinical trials with
multiple therapeutic avenues to lower amyloid-β burden in Alzheimer's disease (AD). In …

Curcumin and Alzheimer's disease

T Hamaguchi, K Ono, M Yamada - CNS neuroscience & …, 2010 - Wiley Online Library
Curcumin has a long history of use as a traditional remedy and food in Asia. Many studies
have reported that curcumin has various beneficial properties, such as antioxidant …

[HTML][HTML] Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathology

Z Jiwaji, SS Tiwari, RX Avilés-Reyes, M Hooley… - Nature …, 2022 - nature.com
Alzheimer's disease (AD) alters astrocytes, but the effect of Aß and Tau pathology is poorly
understood. TRAP-seq translatome analysis of astrocytes in APP/PS1 ß-amyloidopathy and …

The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer's disease

N Lonnemann, S Hosseini… - Proceedings of the …, 2020 - National Acad Sciences
Numerous studies demonstrate that neuroinflammation is a key player in the progression of
Alzheimer's disease (AD). Interleukin (IL)-1β is a main inducer of inflammation and therefore …

[HTML][HTML] Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer's disease

M Calvo-Rodriguez, SS Hou, AC Snyder… - Nature …, 2020 - nature.com
Mitochondria contribute to shape intraneuronal Ca2+ signals. Excessive Ca2+ taken up by
mitochondria could lead to cell death. Amyloid beta (Aβ) causes cytosolic Ca2+ overload …

[HTML][HTML] Vasomotion as a driving force for paravascular clearance in the awake mouse brain

SJ van Veluw, SS Hou, M Calvo-Rodriguez… - Neuron, 2020 - cell.com
Paravascular drainage of solutes, including β-amyloid (Aβ), appears to be an important
process in brain health and diseases such as Alzheimer's disease (AD) and cerebral …

[HTML][HTML] ApoE4 accelerates early seeding of amyloid pathology

CC Liu, N Zhao, Y Fu, N Wang, C Linares, CW Tsai… - Neuron, 2017 - cell.com
Accumulation and aggregation of amyloid-β (Aβ) in the brain is an initiating step in the
pathogenesis of Alzheimer's disease (AD). The ε4 allele of apolipoprotein E (apoE) gene is …

Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease

RE Bennett, AB Robbins, M Hu, X Cao… - Proceedings of the …, 2018 - National Acad Sciences
Mixed pathology, with both Alzheimer's disease and vascular abnormalities, is the most
common cause of clinical dementia in the elderly. While usually thought to be concurrent …

Exosomes isolated from human umbilical cord mesenchymal stem cells alleviate neuroinflammation and reduce amyloid-beta deposition by modulating microglial …

M Ding, Y Shen, P Wang, Z Xie, S Xu, ZY Zhu… - Neurochemical …, 2018 - Springer
Alzheimer's disease (AD) is the most common neurodegenerative disease characterized by
excessive accumulation of the amyloid-β peptide (Aβ) in the brain, which has been …

Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer's disease amyloid plaques

S Gowrishankar, P Yuan, Y Wu… - Proceedings of the …, 2015 - National Acad Sciences
Through a comprehensive analysis of organellar markers in mouse models of Alzheimer's
disease, we document a massive accumulation of lysosome-like organelles at amyloid …